Kelly J Fleetwood, Raied Alotaibi, Stine H Scheuer, Daniel J Smith, Sarah H Wild, Caroline A Jackson
{"title":"Time trends in life expectancy of people with severe mental illness in Scotland, 2000-2019: population-based study.","authors":"Kelly J Fleetwood, Raied Alotaibi, Stine H Scheuer, Daniel J Smith, Sarah H Wild, Caroline A Jackson","doi":"10.1192/bjo.2025.49","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>People with severe mental illness (SMI) have a higher risk of premature mortality than the general population.</p><p><strong>Aims: </strong>To investigate whether the life expectancy gap for people with SMI is widening, by determining time trends in excess life-years lost.</p><p><strong>Method: </strong>This population-based study included people with SMI (schizophrenia, bipolar disorder and major depression) alive on 1 January 2000. We ascertained SMI from psychiatric hospital admission records (1981-2019), and deaths via linkage to the national death register (2000-2019). We used the Life Years Lost (LYL) method to estimate LYL by SMI and sex, compared LYL to the Scottish population and assessed trends over 18 3-year rolling periods.</p><p><strong>Results: </strong>We included 28 797 people with schizophrenia, 16 657 with bipolar disorder and 72 504 with major depression. Between 2000 and 2019, life expectancy increased in the Scottish population but the gap widened for people with schizophrenia. For 2000-2002, men and women with schizophrenia lost an excess 9.4 (95% CI 8.5-10.3) and 8.2 (95% CI 7.4-9.0) life-years, respectively, compared with the general population. In 2017-2019, this increased to 11.8 (95% CI 10.9-12.7) and 11.1 (95% CI 10.0-12.1). The life expectancy gap was lower for bipolar disorder and depression and unchanged over time.</p><p><strong>Conclusions: </strong>The life expectancy gap in people with SMI persisted or widened from 2000 to 2019. Addressing this entrenched disparity requires equitable social, economic and health policies, healthcare re-structure and improved resourcing, and investment in interventions for primary and secondary prevention of SMI and associated comorbidities.</p>","PeriodicalId":9038,"journal":{"name":"BJPsych Open","volume":"11 3","pages":"e103"},"PeriodicalIF":3.9000,"publicationDate":"2025-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJPsych Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1192/bjo.2025.49","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: People with severe mental illness (SMI) have a higher risk of premature mortality than the general population.
Aims: To investigate whether the life expectancy gap for people with SMI is widening, by determining time trends in excess life-years lost.
Method: This population-based study included people with SMI (schizophrenia, bipolar disorder and major depression) alive on 1 January 2000. We ascertained SMI from psychiatric hospital admission records (1981-2019), and deaths via linkage to the national death register (2000-2019). We used the Life Years Lost (LYL) method to estimate LYL by SMI and sex, compared LYL to the Scottish population and assessed trends over 18 3-year rolling periods.
Results: We included 28 797 people with schizophrenia, 16 657 with bipolar disorder and 72 504 with major depression. Between 2000 and 2019, life expectancy increased in the Scottish population but the gap widened for people with schizophrenia. For 2000-2002, men and women with schizophrenia lost an excess 9.4 (95% CI 8.5-10.3) and 8.2 (95% CI 7.4-9.0) life-years, respectively, compared with the general population. In 2017-2019, this increased to 11.8 (95% CI 10.9-12.7) and 11.1 (95% CI 10.0-12.1). The life expectancy gap was lower for bipolar disorder and depression and unchanged over time.
Conclusions: The life expectancy gap in people with SMI persisted or widened from 2000 to 2019. Addressing this entrenched disparity requires equitable social, economic and health policies, healthcare re-structure and improved resourcing, and investment in interventions for primary and secondary prevention of SMI and associated comorbidities.
背景:重度精神疾病(SMI)患者比一般人群有更高的过早死亡风险。目的:通过确定超额寿命年损失的时间趋势,调查重度精神障碍患者的预期寿命差距是否在扩大。方法:这项以人群为基础的研究纳入了2000年1月1日存活的重度精神分裂症患者(精神分裂症、双相情感障碍和重度抑郁症)。我们从精神病院入院记录(1981-2019)中确定重度精神分裂症,并通过与国家死亡登记(2000-2019)的联系确定死亡人数。我们使用生命年损失(LYL)方法根据SMI和性别来估计LYL,将LYL与苏格兰人口进行比较,并评估了18个3年滚动期的趋势。结果:我们纳入了28797名精神分裂症患者,16657名双相情感障碍患者和72504名重度抑郁症患者。2000年至2019年期间,苏格兰人口的预期寿命有所增加,但精神分裂症患者的预期寿命差距扩大了。2000-2002年,与一般人群相比,患有精神分裂症的男性和女性分别多损失了9.4 (95% CI 8.5-10.3)和8.2 (95% CI 7.4-9.0)个生命年。在2017-2019年,这一数字增加到11.8 (95% CI 10.9-12.7)和11.1 (95% CI 10.0-12.1)。双相情感障碍和抑郁症的预期寿命差距较小,并且随着时间的推移保持不变。结论:从2000年到2019年,重度精神分裂症患者的预期寿命差距持续或扩大。要解决这一根深蒂固的差距,需要制定公平的社会、经济和卫生政策,调整保健结构,改善资源配置,并投资于重度精神分裂症及相关合并症的一级和二级预防干预措施。
期刊介绍:
Announcing the launch of BJPsych Open, an exciting new open access online journal for the publication of all methodologically sound research in all fields of psychiatry and disciplines related to mental health. BJPsych Open will maintain the highest scientific, peer review, and ethical standards of the BJPsych, ensure rapid publication for authors whilst sharing research with no cost to the reader in the spirit of maximising dissemination and public engagement. Cascade submission from BJPsych to BJPsych Open is a new option for authors whose first priority is rapid online publication with the prestigious BJPsych brand. Authors will also retain copyright to their works under a creative commons license.